01 18BIOCRYST
01 210125102
02 210329260
03 210662160
04 210689346
05 211117867
06 211230530
07 211618733
08 211708333
09 212116346
01 8Y
02 10Blank
01 2Y
02 16Blank
01 102035-03-09
02 22035-04-07
03 62039-11-01
Patent Expiration Date : 2039-11-01
US Patent Number : 11117867
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 214094
Patent Use Code : U-3010
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-11-01
Patent Expiration Date : 2039-11-01
US Patent Number : 11117867
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 214094
Patent Use Code : U-3010
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-11-01
Patent Expiration Date : 2035-03-09
US Patent Number : 11230530
Drug Substance Claim :
Drug Product Claim :
Application Number : 214094
Patent Use Code : U-3300
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-03-09
Patent Expiration Date : 2035-03-09
US Patent Number : 11230530
Drug Substance Claim :
Drug Product Claim :
Application Number : 214094
Patent Use Code : U-3300
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-03-09
Patent Expiration Date : 2035-03-09
US Patent Number : 11708333
Drug Substance Claim :
Drug Product Claim :
Application Number : 214094
Patent Use Code : U-3300
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-03-09
Patent Expiration Date : 2035-03-09
US Patent Number : 11708333
Drug Substance Claim :
Drug Product Claim :
Application Number : 214094
Patent Use Code : U-3300
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-03-09
Patent Expiration Date : 2035-04-07
US Patent Number : 10125102
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 214094
Patent Use Code : U-3010
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-04-07
Patent Expiration Date : 2035-03-09
US Patent Number : 10689346
Drug Substance Claim :
Drug Product Claim :
Application Number : 214094
Patent Use Code : U-3010
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-03-09
Patent Expiration Date : 2039-11-01
US Patent Number : 10662160
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 214094
Patent Use Code : U-3010
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-11-01
Patent Expiration Date : 2039-11-01
US Patent Number : 10662160
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 214094
Patent Use Code : U-3010
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-11-01
